These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 31924543

  • 1. Outcomes in Patients with Diabetic Macular Edema Requiring Cataract Surgery in VISTA and VIVID Studies.
    Moshfeghi AA, Thompson D, Berliner AJ, Saroj N.
    Ophthalmol Retina; 2020 May; 4(5):481-485. PubMed ID: 31924543
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
    Heier JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, Do DV, Midena E, Boyer DS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Vitti R, Berliner AJ, Zeitz O, Metzig C, Holz FG.
    Ophthalmology; 2016 Nov; 123(11):2376-2385. PubMed ID: 27651226
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
    Do DV, Nguyen QD, Vitti R, Berliner AJ, Gibson A, Saroj N, Soo Y, Boyer DS.
    Ophthalmology; 2016 Apr; 123(4):850-7. PubMed ID: 26832658
    [Abstract] [Full Text] [Related]

  • 5. Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.
    Ehlers JP, Uchida A, Hu M, Figueiredo N, Kaiser PK, Heier JS, Brown DM, Boyer DS, Do DV, Gibson A, Saroj N, Srivastava SK.
    Ophthalmol Retina; 2019 Dec; 3(12):1056-1066. PubMed ID: 31473172
    [Abstract] [Full Text] [Related]

  • 6. Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema: Post Hoc Analyses from VISTA and VIVID.
    Dhoot DS, Baker K, Saroj N, Vitti R, Berliner AJ, Metzig C, Thompson D, Singh RP.
    Ophthalmology; 2018 Jan; 125(1):51-56. PubMed ID: 28764888
    [Abstract] [Full Text] [Related]

  • 7. Prevention of Macular Edema in Patients With Diabetic Retinopathy Undergoing Cataract Surgery: The PROMISE Trial.
    Song W, Conti TF, Gans R, Conti FF, Silva FQ, Saroj N, Singh RP.
    Ophthalmic Surg Lasers Imaging Retina; 2020 Mar 01; 51(3):170-178. PubMed ID: 32211907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies.
    Korobelnik JF, Lu C, Katz TA, Dhoot DS, Loewenstein A, Arnold J, Staurenghi G.
    Ophthalmol Retina; 2019 Aug 01; 3(8):663-669. PubMed ID: 31103642
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
    Clark WL, Boyer DS, Heier JS, Brown DM, Haller JA, Vitti R, Kazmi H, Berliner AJ, Erickson K, Chu KW, Soo Y, Cheng Y, Campochiaro PA.
    Ophthalmology; 2016 Feb 01; 123(2):330-336. PubMed ID: 26522708
    [Abstract] [Full Text] [Related]

  • 11. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
    Bahrami B, Hong T, Zhu M, Schlub TE, Chang A.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun 01; 255(6):1133-1140. PubMed ID: 28238195
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study.
    Wykoff CC, Shah C, Dhoot D, Coleman HR, Thompson D, Du W, Baker K, Vitti R, Berliner AJ, Metzig C, Saroj N.
    Ophthalmology; 2019 Aug 01; 126(8):1171-1180. PubMed ID: 30946887
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Time to Resolution of Diabetic Macular Edema after Treatment with Intravitreal Aflibercept Injection or Laser in VISTA and VIVID.
    Valentim CCS, Singh RP, Du W, Moini H, Talcott KE.
    Ophthalmol Retina; 2023 Jan 01; 7(1):24-32. PubMed ID: 35843487
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema.
    Moshfeghi AA, Shapiro H, Lemmon LA, Gune S.
    Ophthalmol Retina; 2018 Feb 01; 2(2):86-90. PubMed ID: 31047350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.